Cited 19 times in
A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-line chemotherapy for advanced pancreatic cancer in South Korea.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.